Press Release Archive
-
DePuy Synthes Announces Agreement with Blue Belt Technologies, Inc. Agreement enables access to the SIGMA® HP Partial Knee on the Navio™ Surgical System
-
Johnson & Johnson Announces New Grant to Harvard Medical School to Combat Drug-Resistant TuberculosisNew collaboration will help address significant global unmet needs in pediatric drug-resistant tuberculosis (DR-TB) treatment and optimize use of existing DR-TB treatments
-
Cordis Corporation Launches INCRAFT® AAA Stent Graft System for Treatment of Abdominal Aortic Aneurysms (AAA)Innovative AAA Device Offers New, Less Invasive Option for Patients and Physicians
-
Johnson & Johnson to Participate in 2014 Morgan Stanley Health Care Conference
-
Johnson & Johnson Responds to Ebola Crisis with Commitment to Accelerate Vaccine Program in Collaboration with the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
-
New Data Show Once-Daily XARELTO® May Be an Alternative to Vitamin K Antagonists in Treating Atrial Fibrillation Patients Undergoing Elective CardioversionX-VeRT Study Results Presented as a Hot Line Session at the ESC Congress 2014 and Published in European Heart Journal
-
Janssen Expands EXPLORER Global Cardiovascular Research Program to Evaluate the Role of XARELTO® in Addressing Critical Medical NeedsNew Studies Grow XARELTO® Clinical Development Program to More Than 275,000 Patients
-
Janssen Diagnostics Expands Research Portfolio to Include Next-Generation SequencingEnhanced Offering to Enable ‘Dynamic Monitoring’ in Cancer Research
-
Ethicon Expands Bariatric Surgery Portfolio; Unveils “Evidence Corner” At IFSO To Address Obesity And Metabolic DiseasesHighlights New Stapler System and Advanced Energy Devices, and Provides Forum for New Evidence Generation
-
Janssen Affiliate Cilag GmbH International Acquires Covagen AGClinical Candidate COVA 322 and FynomAb® Technology Platform Further Strengthen Immunology Portfolio and Capabilities